Compare HCA Health Inc (HCA) vs Shell PLC (SHEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Shell PLC — how do they compare? HCA Health Inc trades at $443.69 (market cap $96.35B), while Shell PLC trades at $100.2 (market cap $284.34B). The key difference: Shell PLC is far larger — about 3× HCA Health Inc's market cap, and Shell PLC pays the higher dividend (3.12%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Shell PLC for 90 Days on average.
| HCA | SHEL | |
|---|---|---|
Market Cap | $96.35B | $284.34B |
Volume | 1,079,453 | 9,097,469 |
Sector | Health | Energy |
52-Week High | $545.13 | $100.20 |
52-Week Low | $361.32 | $70.31 |
Typical Hold Time | 76 Days | 90 Days |
Enterprise Value | $146.88B | $326.04B |
Dividend Yield | 0.7% | 3.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.
The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.
Shell (SHEL) trades at $96.85, down 0.79% on the day, with strong technical momentum indicated by bullish moving averages and a 52-week high near $99.16. The company shows solid fundamentals with a P/E of 10.71 and ROE of 14.35%, while recent earnings beat expectations in Q1 and Q2 2026. Key developments include the approval of LNG Canada Phase 2 expansion, doubling export capacity, and strategic portfolio optimization through asset divestments.
Outlook remains positive with analyst consensus at Buy (61.5%) and a $102.53 price target, though risks include volatile energy prices and execution challenges in major projects. The stock offers value through attractive valuation metrics and growth in LNG operations, supported by strong cash flow generation despite recent revenue declines from 2022 peaks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →
